Última actualización: Agosto 16, 2026
Medicina regenerativa y longevidad saludable: Lo que la ciencia sabe hoy sobre las células madre mesenquimales
Durante las últimas dos décadas, Las tecnologías celulares han evolucionado desde un concepto experimental hasta convertirse en uno de los campos de más rápido crecimiento de la ciencia biomédica traslacional..
Hoy, La medicina regenerativa ya no se centra exclusivamente en el tratamiento de enfermedades en fase avanzada..
Cada vez hay más investigaciones dedicadas a comprender cómo funciona el envejecimiento biológico., estrés fisiológico crónico, La desregulación inmune y la disminución del potencial regenerativo pueden estudiarse y abordarse antes de que se desarrollen cambios patológicos irreversibles..
El envejecimiento comienza mucho antes de lo que la mayoría de la gente supone
Contrariamente a la creencia común, El envejecimiento biológico no comienza repentinamente en la vejez..
La biología molecular moderna muestra que los cambios relacionados con la edad se pueden medir ya en la tercera y cuarta décadas de la vida..
Estos incluyen:
• disfunción endotelial progresiva;
• aumento del estrés oxidativo;
• chronic low-grade inflammation;
• reduced mitochondrial efficiency;
• gradual remodeling of the immune system;
• decreased regenerative potential;
• slower recovery after prolonged physical or psychological stress.
Most people remain clinically healthy during this period. Sin embargo, molecular changes continue to accumulate silently for many years before clinically evident disease appears.
From the perspective of regenerative medicine, this period represents an important opportunity to support the body’s physiological resilience while its own repair mechanisms remain active.
Mesenchymal Stem Cells — Biological Coordinators of Regeneration
Células madre mesenquimales (MSC) are among the most widely studied cellular populations in regenerative medicine.
Current scientific evidence indicates that their primary function is not the direct replacement of damaged tissues.
De lo contrario, MSC function as biological centers of cellular signaling.
After intravenous administration, they release a complex secretome composed of hundreds of biologically active molecules, incluido:
• growth factors;
• cytokines;
• extracellular vesicles;
• exosomes;
• immunomodulatory proteins.
Juntos, these signaling molecules influence numerous physiological processes involved in tissue repair and adaptation.
MSC-mediated signaling mechanisms may contribute to:
• physiological regulation of inflammation;
• maintenance of endothelial function;
• vascular homeostasis;
• improvement of microcirculation;
• tissue repair processes;
• maintenance of mitochondrial function;
• immune regulation;
• interaction between the body’s own stem cell populations.
It is precisely these biological properties that explain why MSC continue to attract considerable interest across different areas of regenerative medicine.
Biological Recovery After Chronic Stress
Chronic psychological stress is increasingly considered a systemic biological factor, not merely an emotional state.
Prolonged activation of stress mechanisms may influence:
• immune balance;
• inflammatory signaling;
• sleep quality;
• metabolic regulation;
• vascular function;
• cellular energy metabolism;
• overall physiological resilience of the body.
A Scientific Concept of Biological Recovery
Células madre SBN has been developed as a regenerative medicine program designed to support biological recovery through advanced cellular technologies.
Rather than focusing on a single organ system, this concept recognizes that biological aging and chronic physiological stress involve multiple interconnected biological networks.
The scientific objective of the program is to support the body’s intrinsic repair mechanisms through carefully selected regenerative cellular technologies administered within accredited clinical environments.
Two Regenerative Strategies
Opción 1
Allogeneic Regenerative Cells from a Certified Cell Bank
The first approach utilizes donor-derived regenerative cells that undergo preparation and rigorous quality control within specialized cell banking facilities.
Because the cellular product is prepared in advance, the clinical procedure can generally be completed during a single visit.
Opción 2
Personalized Autologous Mesenchymal Stem Cells
The second approach is based on a personalized protocol.
Durante la primera visita, a small blood sample is collected for laboratory processing and expansion of the patient’s own regenerative cell population under GMP-compliant condiciones.
Following laboratory cultivation, the expanded autologous cells are administered intravenously during a second visit approximately one week later.
This approach is intended to provide a substantially greater concentration of regenerative cells than is naturally present in peripheral circulation while using exclusively the patient’s own cellular material.
Why Barcelona?
El Células madre SBN clinical program is delivered through our clinical infrastructure in Barcelona.
The city combines internationally recognized medical facilities, GMP-certified laboratory capabilities, and multidisciplinary clinical teams with extensive experience in regenerative medicine.
All clinical procedures are performed in accordance with the applicable legal and regulatory framework of the country in which the treatment is provided.
Scientific Perspective
Regenerative medicine is transforming our understanding of human health.
Históricamente, medicine has focused primarily on the diagnosis and treatment of disease.
Cell-based regenerative technologies introduce a complementary paradigm: supporting the body’s endogenous repair mechanisms before functional decline reaches clinical significance.
The growing body of experimental and clinical evidence highlights the importance of inflammation modulation, enhancement of tissue repair, support of vascular biology, and optimization of immune regulation.
El Células madre SBN program has been developed within this scientific framework.
Referencias científicas seleccionadas
Pittenger MF et al.. Perspectiva de las células madre mesenquimales: Biología celular al progreso clínico. Medicina Regenerativa NPJ. 2019.
Caplan AI. Células madre mesenquimales: Es hora de cambiar el nombre! Medicina traslacional de células madre. 2017.
Lunyak VV, Amaro Ortiz A, Gaur M. Secretoma de células madre mesenquimales en la reparación y regeneración de tejidos. Fronteras en biología celular y del desarrollo. 2022.
Golpaniano S et al.. Infusiones alogénicas de células madre mesenquimales humanas para la fragilidad del envejecimiento (Ensayo CRATUS). Journal of Gerontology: Series A.
Tompkins BA y otros. Terapia con células madre mesenquimales para la fragilidad del envejecimiento. Journal of Gerontology: Series A.
These publications reflect the rapidly expanding scientific literature on mesenchymal stem cell biology, inmunomodulación, regenerative signaling, and their potential applications in age-related physiological decline.
Revisión de casos científicos
¿Le gustaría saber si los programas clínicos actuales, desarrollos recientes de investigación, o enfoques emergentes pueden ser relevante para su situación individual?
Envía tu pregunta a nuestro equipo científico. La oficina central de NBScience en el Reino Unido coordina consultas a través de la red internacional de centros médicos, científicos, y consultores especializados.
- Revisión de la información que proporcionas.
- Información relevante sobre programas clínicos y de investigación.
- Una respuesta clara y centrada en tu situación.
Sin compromiso. Su pregunta será revisada de forma confidencial..
Información educativa y de investigación únicamente.. Este servicio no constituye consejo médico, diagnóstico, prescripción, o un personalizado recomendación de tratamiento.
